Trexquant Investment LP Erasca, Inc. Transaction History

Trexquant Investment LP

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	SELL	$3.89 - $8.57 $58,034 - $127,855	-14,919 Reduced 43.47%	19,403 $83,000
Q3 2022 Nov 14, 2022	SELL	$5.82 - $10.68 $209,281 - $384,042	-35,959 Reduced 51.16%	34,322 $268,000
Q2 2022 Aug 11, 2022	BUY	$4.58 - $8.72 $321,886 - $612,850	70,281 New	70,281 $391,000

117

74.3M

7.1K

40.1K

Ticker ERAS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 122,147,000
Market Cap $265M
Description
Erasca, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers. The company's lead candidates include ERAS-007, an oral inhibitor of ERK1/2 for the treatment of non-small cell lung cancer, colorectal cancer, and acute myeloid leukemia; ...

Get notified when there are updates to the investment portfolio of Trexquant Investment LP, based on Form 13F filings with the SEC.

Stay updated on Trexquant Investment LP with notifications on news.